Expect loss of range of motion, loss of strength, myopathy, impaired balance, reduced mobility and walking ability and other musculoskeletal and functional deficits as well as anxiety, depression, PTSD and sleep disorders. READ MORE

Elderly patient populations face vulnerabilities to adverse effects and interaction because of complex medication regimes and comorbid conditions. READ MORE

“We are already seeing improved outcomes and will have better outcomes coming in the future,” said Sharon A. Chung, MD, MAS. READ MORE

Precision medicine shifts away from the more one-size-fits-all medicine models, and genomics offers an important tool for enabling personalized medicine. READ MORE

“Probably the most important reason people with rheumatic diseases are not exercising is that they are not getting the message that physical activity is a good thing for them,” said Patricia Katz, PhD. READ MORE

An ACR Convergence 2020 session saluted those who thrive while living with chronic illnesses and looked at the common traits in those populations. READ MORE

The COVID-19 pandemic has accelerated the growth and overall acceptance of telemedicine in rheumatology and cemented its place as an important facet of care. READ MORE

Empathy as a science needs to be elevated, exploited, and adopted—and researched—to provide patients the best care. READ MORE

The second phase of the Accelerating Medicines Partnership is changing the way researchers look at rheumatoid arthritis, with deeper clinical, histological, and molecular data integrated across samples and between modalities. READ MORE

The Rheumatoid Arthritis Practice Performance (RAPP) project launched to address care gaps in RA disease control, which often center around how disease activity is measured. READ MORE